top of page


Feminai
Feminai is transforming breast cancer screening by enabling early detection from home through an AI-powered wearable device. Their patented technology has demonstrated 96% sensitivity and 98% NPV in clinical trials at Sheba Medical Center. With initial SAFE funding secured and strong clinical results, they’re now preparing for a US pilot in Q3.

Batch 17
Karny Ilan, MD
Co-founder & CEO
Feminai
Dr. Karny Ilan is a general surgeon and CEO of Feminai, developing AI-powered at-home breast cancer screening. A Forbes 30 Under 30 honoree, she graduated with honors from Ben-Gurion University and has led research and innovation at the intersection of health and technology.
bottom of page